Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.

Japanese journal of clinical oncology - 6 Jul 2026

Yasuda Yosuke, Yoshida Soichiro, Ikeda Sadakatsu, Yonese Ichiro, Sano Yuta, Urasaki Tetsuya, Nakamura Yuki, Tanaka Hajime, Ito Masaya, Miura Yuji, Numao Noboru, Matsuoka Yoh, Koga Fumitaka, Yonese Junji, Fujii Yasuhisa

Abstract excerpt

INTRODUCTION: Comprehensive genomic profiling (CGP) has expanded treatment options for metastatic castration-resistant prostate cancer (mCRPC); however, real-world data on its clinical utility in Japanese patients remain limited. To address this gap, we conducted a multicenter real-world analysis to evaluate the implementation and clinical relevance of CGP in Japanese patients with mCRPC. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Genomics

Share to Microsatellite Instability

Share to Mutation

Share to Neoplasm Metastasis

Share to Prostatic Neoplasms, Castration-Resistant

Source

Identifiers

PMID: 41818716
DOI: 10.1093/jjco/hyag039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world insights from comprehensive genomic profiling in patients with metastatic castration-resistant prostate cancer.PMID 41818716Read ↗

The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan.Semantic proximity Read ↗

Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease ProgressionSemantic proximity Read ↗

Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study.Semantic proximity Read ↗

Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance.Semantic proximity Read ↗

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerSemantic proximity Read ↗

Cancer Genomic Medicine for Urological Malignancies in Japan.Semantic proximity Read ↗

Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors.Semantic proximity Read ↗

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.Semantic proximity Read ↗

A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancerSemantic proximity Read ↗

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.Semantic proximity Read ↗

Precision medicine for advanced prostate cancer.Semantic proximity Read ↗

Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning PlatformSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.